JP3190465B2 - Stable liquid products containing fat-soluble substances - Google Patents
Stable liquid products containing fat-soluble substancesInfo
- Publication number
- JP3190465B2 JP3190465B2 JP00321993A JP321993A JP3190465B2 JP 3190465 B2 JP3190465 B2 JP 3190465B2 JP 00321993 A JP00321993 A JP 00321993A JP 321993 A JP321993 A JP 321993A JP 3190465 B2 JP3190465 B2 JP 3190465B2
- Authority
- JP
- Japan
- Prior art keywords
- fat
- glycerin
- soluble
- water
- phase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000126 substance Substances 0.000 title claims abstract description 17
- 239000012263 liquid product Substances 0.000 title claims description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 11
- 239000003381 stabilizer Substances 0.000 claims abstract description 3
- 235000011187 glycerol Nutrition 0.000 claims description 15
- 239000012071 phase Substances 0.000 claims description 11
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 claims description 9
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 claims description 9
- 235000010385 ascorbyl palmitate Nutrition 0.000 claims description 9
- 235000021466 carotenoid Nutrition 0.000 claims description 9
- 150000001747 carotenoids Chemical class 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 3
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 claims description 3
- 235000019155 vitamin A Nutrition 0.000 claims description 3
- 239000011719 vitamin A Substances 0.000 claims description 3
- 235000019166 vitamin D Nutrition 0.000 claims description 2
- 239000011710 vitamin D Substances 0.000 claims description 2
- 235000019165 vitamin E Nutrition 0.000 claims description 2
- 239000011709 vitamin E Substances 0.000 claims description 2
- 235000019168 vitamin K Nutrition 0.000 claims description 2
- 239000011712 vitamin K Substances 0.000 claims description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims 1
- 229930003316 Vitamin D Natural products 0.000 claims 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims 1
- 229930003427 Vitamin E Natural products 0.000 claims 1
- 229930003448 Vitamin K Natural products 0.000 claims 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims 1
- 150000003710 vitamin D derivatives Chemical class 0.000 claims 1
- 229940046009 vitamin E Drugs 0.000 claims 1
- 150000003721 vitamin K derivatives Chemical class 0.000 claims 1
- 229940045997 vitamin a Drugs 0.000 claims 1
- 229940046008 vitamin d Drugs 0.000 claims 1
- 229940046010 vitamin k Drugs 0.000 claims 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract description 4
- 150000002148 esters Chemical class 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 abstract description 3
- 235000010323 ascorbic acid Nutrition 0.000 abstract description 2
- 229960005070 ascorbic acid Drugs 0.000 abstract description 2
- 239000011668 ascorbic acid Substances 0.000 abstract description 2
- 150000004668 long chain fatty acids Chemical class 0.000 abstract description 2
- 239000012530 fluid Substances 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 239000000047 product Substances 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 239000000839 emulsion Substances 0.000 description 13
- 239000000203 mixture Substances 0.000 description 11
- 235000013734 beta-carotene Nutrition 0.000 description 8
- 239000011648 beta-carotene Substances 0.000 description 8
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 8
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 7
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 7
- 229960002747 betacarotene Drugs 0.000 description 7
- 235000013305 food Nutrition 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 235000011121 sodium hydroxide Nutrition 0.000 description 5
- 150000005846 sugar alcohols Chemical class 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 4
- 239000013543 active substance Substances 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- 239000000084 colloidal system Substances 0.000 description 3
- 230000001804 emulsifying effect Effects 0.000 description 3
- -1 fatty acid ester Chemical class 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 102220547770 Inducible T-cell costimulator_A23L_mutation Human genes 0.000 description 2
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 2
- 235000019486 Sunflower oil Nutrition 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- FDSDTBUPSURDBL-LOFNIBRQSA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-LOFNIBRQSA-N 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000021056 liquid food Nutrition 0.000 description 2
- 239000012669 liquid formulation Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 229940108325 retinyl palmitate Drugs 0.000 description 2
- 235000019172 retinyl palmitate Nutrition 0.000 description 2
- 239000011769 retinyl palmitate Substances 0.000 description 2
- 102220229106 rs753340463 Human genes 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000002600 sunflower oil Substances 0.000 description 2
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- GVJHHUAWPYXKBD-QLVXXPONSA-N (S,R,R)-alpha-tocopherol Chemical compound [H][C@@](C)(CCCC(C)C)CCC[C@@]([H])(C)CCC[C@@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2C GVJHHUAWPYXKBD-QLVXXPONSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- OOUTWVMJGMVRQF-DOYZGLONSA-N Phoenicoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)CCC2(C)C OOUTWVMJGMVRQF-DOYZGLONSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000012682 canthaxanthin Nutrition 0.000 description 1
- 239000001659 canthaxanthin Substances 0.000 description 1
- 229940008033 canthaxanthin Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000015270 fruit-flavoured drink Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 239000012875 nonionic emulsifier Substances 0.000 description 1
- 150000003904 phospholipids Chemical group 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/40—Colouring or decolouring of foods
- A23L5/42—Addition of dyes or pigments, e.g. in combination with optical brighteners
- A23L5/43—Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives
- A23L5/44—Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives using carotenoids or xanthophylls
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、脂溶性物質の新規液体
製剤及び該製品の製法に関する。このような生理学的に
認容される製剤は、特に液体食品及び飼料に使用され
る。The present invention relates to a novel liquid formulation of a fat-soluble substance and to a method for producing the product. Such physiologically acceptable preparations are used in particular for liquid foods and feeds.
【0002】[0002]
【従来の技術】生理学的に有効な脂溶性物質は、身体に
容易に吸収されるように水中に分散しかつ微細に分散し
なければならない。一般に、適当な製品は、保護コロイ
ドを含有し、付加的に乳化剤を含有していてもよい水相
中で、脂溶性又は食用油に溶解する物質を乳化すること
により製造される。該保護コロイドは、脂溶性相を包囲
し、分散を安定させ、必要とされる水中での分散性の原
因となる。しばしば保護コロイドとして使用される該物
質は、ゼラチン、アラビア・ゴム、デキストリン、デン
プン及びその他の天然物質である。これらのすべてに共
通することは、微生物学的に腐敗しやすく、一般に長期
にわたっては、製剤に防腐剤を添加しない限り、乾燥し
た形でのみ貯蔵できるにすぎないということである。し
かしながら、防腐剤を添加することは多くの場合望まし
くない。この理由から、該製品を液状媒体で使用するこ
とを目的とし、ひいては混合が容易であることから液体
製剤が有利でありうるという場合でも、しばしば分散の
後に乾燥工程が実施される。BACKGROUND OF THE INVENTION Physiologically effective fat-soluble substances must be dispersed and finely dispersed in water so that they are easily absorbed by the body. In general, suitable products are prepared by emulsifying a fat-soluble or edible oil-soluble substance in an aqueous phase containing a protective colloid and optionally containing an emulsifier. The protective colloid surrounds the fat-soluble phase, stabilizes the dispersion and causes the required dispersibility in water. The substances often used as protective colloids are gelatin, gum arabic, dextrin, starch and other natural substances. Common to all of these is that they are microbiologically perishable and generally can only be stored over a long period of time in dry form unless preservatives are added to the formulation. However, the addition of preservatives is often undesirable. For this reason, a drying step is often carried out after dispersion, even if the aim is to use the product in a liquid medium and thus a liquid formulation may be advantageous because of the ease of mixing.
【0003】該製品の腐敗を回避するための1つの可能
性としては、水相に高い濃度の糖を加えることである。
ドイツ国特許第2363534号明細書には、安定させ
るために生理学的に認容される乳化剤、例えばレシチン
またはアスコルビルパルミテートを使用した、相応する
糖を含有する液体ビタミン及びカロチノイド製品の製造
が記載されている。しかしながら、この種の製品の欠点
は、例えば該製品を低温で貯蔵する際に、糖又は糖アル
コールが結晶する傾向にあるということであり、これは
好ましくない不均質を引き起こす。更に、良好な流動特
性は糖又は糖アルコールの多い含量に起因して、常には
保証されない。これらの欠点は、連続相として液体で生
理学的に認容されるポリアルコール、例えばグリセリン
を使用することにより回避することができる。[0003] One possibility for avoiding spoilage of the product is to add high concentrations of sugar to the aqueous phase.
German Patent No. 2,363,534 describes the production of liquid vitamin and carotenoid products containing the corresponding sugars using a physiologically acceptable emulsifier for stabilization, such as lecithin or ascorbyl palmitate. I have. However, a disadvantage of this type of product is that the sugar or sugar alcohol tends to crystallize, for example, when the product is stored at low temperatures, which causes undesirable heterogeneity. Moreover, good flow properties are not always guaranteed due to the high content of sugars or sugar alcohols. These disadvantages can be avoided by using a liquid, physiologically acceptable polyalcohol, such as glycerin, as the continuous phase.
【0004】ヨーロッパ特許第0361928号明細書
には、グリセリン/水の混合物を連続相として有する極
度に微粒子状のエマルジョンの製造方法が記載されてい
る。その際、該乳化剤は燐脂質又は非イオン性乳化剤で
ある。実施例に記載された該エマルジョンは、3ヶ月の
期間にわたってのみ変化しないにすぎない。EP 0 361 928 describes a process for the preparation of extremely fine emulsions having a glycerin / water mixture as the continuous phase. The emulsifier is a phospholipid or a nonionic emulsifier. The emulsions described in the examples only change over a period of three months.
【0005】カロチノイド又はビタミンを含有するエマ
ルジョン中でポリアルコールを使用することが記載され
ている他の特許明細書では、アルコール、例えばエタノ
ール(特開昭47−25220号公報)、非イオン性乳
化剤、例えばポリグリセリン脂肪酸エステル、(特公昭
61−260860号公報)又はその両方(特公昭60
−000419号公報)を付加的に使用することが必要
である。Other patents which describe the use of polyalcohols in emulsions containing carotenoids or vitamins include alcohols such as ethanol (JP 47-25220), nonionic emulsifiers, For example, polyglycerin fatty acid ester, (JP-B-61-260860) or both (JP-B-60-260)
-000419) must be additionally used.
【0006】しかしながら、アルコール及び非イオン性
乳化剤は、多くの製剤、特に食品用として好ましくない
か、又は一般的に食品中での使用は認可されていない。
特公昭58−128141号公報には、更にグリセリン
又はその他の多価アルコールをベースとし、軟質のゼラ
チンカプセルに充填するために使用されるカロチノイド
エマルジョンの製造方法が記載されている。実施例で使
用された乳化剤は、同様に非イオン性乳化剤であり、か
つ比較的低い活性物質の含量がもう1つの欠点とみなさ
れる。However, alcohols and nonionic emulsifiers are not preferred for many formulations, especially foodstuffs, or are generally not approved for use in foodstuffs.
JP-B-58-128141 further describes a process for producing carotenoid emulsions based on glycerin or other polyhydric alcohols and used for filling soft gelatin capsules. The emulsifiers used in the examples are likewise nonionic emulsifiers, and the relatively low active substance content is regarded as another disadvantage.
【0007】[0007]
【発明が解決しようとする課題】従って、本発明の解決
する課題は、脂溶性物質を含有し、かつ長期間(6ヶ月
以上)にわたり安定で、上記の欠点を有しない液体製品
を提供することであった。Accordingly, an object of the present invention is to provide a liquid product which contains a fat-soluble substance, is stable for a long period of time (6 months or more), and does not have the above-mentioned disadvantages. Met.
【0008】[0008]
【課題を解決するための手段】上記課題は、必須成分と
して、 a)分散相として少なくとも1つの微細に分散した、生
理学的に認容される脂溶性物質、 b)連続相としてグリセリン又は水と混合したグリセリ
ン、及び c)乳化剤及び安定剤として長鎖状の脂肪酸を有するア
スコルビン酸のエステルを含有する製品により解決され
ることを見出した。The object of the invention is to provide, as essential components: a) at least one finely dispersed, physiologically acceptable fat-soluble substance as a disperse phase; b) a mixture with glycerin or water as a continuous phase. Glycerin and c) ascorbic acid esters having long-chain fatty acids as emulsifiers and stabilizers.
【0009】適当な生理学的に認容される、脂溶性物質
は、例えば脂溶性ビタミンA、D、E又はK並びにカロ
チノイド、例えばカンタキサンチン、アスタキサンチ
ン、ゼアキサンチン、リコピン、アポカロチナール及び
特にβ−カロチンである。カロチノイドは、多種の食品
に極度に微粒子状で存在し、それらに特有な色を付与す
る、自然界で広範囲に生成する顔料である。従って、一
般に公知のプロビタミンA効果の他に、食品、飼料及び
製薬学的な工業用着色剤としても重要である。高い濃度
のカロチノイド製品(例えば、10%の乾燥粉末)によ
り得られる色は、一般にオレンジから赤の範囲に及ぶ。
本発明による、高い濃度でβ−カロチンを含有する製品
は、多種の食品に所望される光沢のある黄色い色相、並
びに高い着色力により優れている。従って、脂溶性の適
当な物質は、多不飽和脂肪酸のグリセリド、例えば小麦
油、ひまわり油、コーン油等、又は上記油の混合物であ
る。最終的には、人体又は動物の体で生理学的に作用
し、水中で不溶性であることから一般にはエマルジョン
又は水中で分散可能な粉末に加工されるすべての脂溶性
物質は、極一般的に該製品の成分として適している。[0009] Suitable physiologically acceptable fat-soluble substances are, for example, fat-soluble vitamins A, D, E or K and carotenoids such as canthaxanthin, astaxanthin, zeaxanthin, lycopene, apocarotinal and especially β-carotene. Carotenoids are extremely naturally occurring pigments that are present in extremely fine particulate form in many foods and impart a unique color to them. Therefore, in addition to the commonly known provitamin A effect, it is also important as a food, feed and pharmaceutical industrial colorant. Colors obtained with high concentrations of carotenoid products (eg, 10% dry powder) generally range from orange to red.
The products according to the invention, which contain high concentrations of β-carotene, are distinguished by a shiny yellow hue, which is desired for a wide variety of foods, as well as by a high tinting strength. Thus, suitable fat-soluble substances are glycerides of polyunsaturated fatty acids, such as, for example, wheat oil, sunflower oil, corn oil and the like, or mixtures of said oils. Ultimately, all liposoluble substances that act physiologically in the human or animal body and are generally insoluble in water and thus processed into emulsions or powders dispersible in water are very generally Suitable as a component of the product.
【0010】生理学的に認容される脂溶性物質の濃度
は、通常製品の重量に対して1〜50%、有利には10
〜40%、更に有利には20〜30%である。しかしな
がら、本来難溶性のβ−カロチンは、通常製品の重量に
対して1〜20%、有利には5〜15%の濃度で存在す
る。[0010] The concentration of the physiologically acceptable fat-soluble substance is usually from 1 to 50%, preferably from 10 to 50% by weight of the product.
4040%, more preferably 20-30%. However, β-carotene, which is poorly soluble in nature, is usually present in a concentration of 1 to 20%, preferably 5 to 15%, by weight of the product.
【0011】グリセリンの量は、通常製品の重量に対し
て一般に99〜50%、有利には80〜60%である
が、該グリセリンは部分的に、グリセリン:水の重量比
が100:0〜50:50の範囲内で水と交換すること
ができる。The amount of glycerin is generally from 99 to 50%, preferably from 80 to 60%, based on the weight of the product, but the glycerin is partly based on a weight ratio of glycerin: water of from 100: 0. Water can be exchanged within the range of 50:50.
【0012】特に有利なアスコルビン酸のエステルは、
C16〜C18−脂肪酸のエステル、特にアスコルビルパル
ミテートである。Particularly advantageous esters of ascorbic acid are
Esters of C 16 -C 18 -fatty acids, in particular ascorbyl palmitate.
【0013】更に、アスコルビルパルミテートの乳化作
用は、塩、特にアルカリ金属塩の形成、一般的には苛性
ソーダ溶液を通常0.5〜1モル量で添加することによ
りナトリウム塩を形成することによりなお高めることが
できる。Further, the emulsifying action of ascorbyl palmitate can be further enhanced by the formation of salts, especially alkali metal salts, generally by the addition of caustic soda solution, usually in a 0.5-1 molar amount, to form the sodium salt. Can be enhanced.
【0014】アスコルビルパルミテートは、食品及び飼
料工業で広範に使用され、更に酸化防止効果を有し、カ
ロチノイド及び多種のビタミンの安定性を高める生理学
的に認容される乳化剤である。該酸化防止効果は、公知
のように、付加的に脂溶性相にトコフェロールを混合す
ることにより更に高めることができる。[0014] Ascorbyl palmitate is a physiologically acceptable emulsifier that is widely used in the food and feed industries, further has an antioxidant effect, and enhances the stability of carotenoids and various vitamins. The antioxidant effect can be further increased, as is known, by additionally mixing tocopherol with the fat-soluble phase.
【0015】本発明による製品は、常法で、例えばグリ
セリン相中に作用物質を含有する脂肪相を乳化させるこ
とにより製造することができる。The products according to the invention can be manufactured in a customary manner, for example by emulsifying a fatty phase containing the active substance in a glycerin phase.
【0016】該分散液は、例えば酸性のpHを有する飲
料のような水性の系においてさえも高い安定性を有す
る。本発明による製品のもう1つの利点は、特定の食品
に要求される、脂溶性物質の含量が高くても僅かな混濁
を示すに過ぎないことである。The dispersion has a high stability even in aqueous systems, for example beverages having an acidic pH. Another advantage of the products according to the invention is that they show only a slight turbidity at high fat-soluble substance content required for certain food products.
【0017】分散相での粒度は5μm未満、特に0.5
μm未満である。本発明の目的を達成するための脂溶性
物質は、特に脂溶性ビタミン、例えばビタミンA、D、
E及びK並びに多不飽和脂肪酸からなる脂肪及びカロチ
ノイドである。The particle size in the dispersed phase is less than 5 μm, especially 0.5
It is less than μm. Fat-soluble substances for achieving the object of the present invention are, in particular, fat-soluble vitamins such as vitamins A, D,
Fats and carotenoids consisting of E and K and polyunsaturated fatty acids.
【0018】作用物質を含有する油相の製品中に存在す
る別の物質に対する割合は、一般に1:99〜50:5
0であり、分散される脂溶性物質の特性並びに均質でか
つ微細な分散に対する要求度に左右される。The ratio of the oil phase containing the active substance to the other substances present in the product is generally from 1:99 to 50: 5.
0, depending on the properties of the fat-soluble substance to be dispersed and the demand for homogeneous and fine dispersion.
【0019】新規の安定した液体製品は、例えばビタミ
ンを液体食品又は飼料に添加するための、又はβ−カロ
チンの場合には、飲料、例えばフルーツ香味付け飲物を
着色するための容易でかつ正確な調合のために極めて適
している。The novel stable liquid products are easy and accurate for adding vitamins to liquid foods or feeds, or in the case of β-carotene, for coloring beverages, for example fruit flavored drinks. Very suitable for compounding.
【0020】[0020]
【実施例】次に、本発明を以下の実施例につき詳細に説
明する。Next, the present invention will be described in detail with reference to the following examples.
【0021】例1 1000mlのビーカーにグリセリン450gを装入
し、3M苛性ソーダ溶液4.8gを加え、該混合物を水
浴中で75℃に加熱した。アスコルビルパルミテート6
gを加え、次いで該混合物を電磁撹拌機で殆ど透明な溶
液になるまで撹拌した。ホモジナイザー(例えば Ultra
turrax(R))を5分間使用して、該溶液中、酢酸−D,
L−α−トコフェロール205gを乳化させた。Example 1 A 1000 ml beaker was charged with 450 g of glycerin, 4.8 g of a 3M sodium hydroxide solution was added, and the mixture was heated to 75 ° C. in a water bath. Ascorbyl Palmitate 6
g was then added and the mixture was stirred with a magnetic stirrer until an almost clear solution. Homogenizer (eg Ultra
turrax®) in the solution for 5 minutes.
205 g of L-α-tocopherol was emulsified.
【0022】得られたエマルジョンを30℃に冷却し、
引続き800バールで高圧ホモジナイザーを1回通過さ
せることにより均質化した。該エマルジョンは、平均粒
度0.2μm及び30%の酢酸トコフェロール含量を有
していた。The resulting emulsion is cooled to 30 ° C.
The mixture was subsequently homogenized by passing once through a high-pressure homogenizer at 800 bar. The emulsion had an average particle size of 0.2 μm and a tocopherol acetate content of 30%.
【0023】例2 例1に類似して、グリセリン480g、3M苛性ソーダ
溶液3.2g、アスコルビルパルミテート4g及びビタ
ミンAパルミテート130gからなる混合物を最初に6
0℃で5分間乳化させた。引続き該エマルジョンを40
℃に冷却し、800バールの高圧ホモジナイザーを1回
通過させて均質化した。平均粒度0.3μm及びビタミ
ンAパルミメート20%の作用物質含量を有するエマル
ジョンが得られた。Example 2 Analogously to Example 1, a mixture consisting of 480 g of glycerin, 3.2 g of a 3M sodium hydroxide solution, 4 g of ascorbyl palmitate and 130 g of vitamin A palmitate was initially charged with 6 g.
Emulsified at 0 ° C. for 5 minutes. The emulsion was then added to 40
C. and homogenized by passing once through an 800 bar high pressure homogenizer. An emulsion having an average particle size of 0.3 μm and an active substance content of 20% vitamin A palmitate was obtained.
【0024】例3 例1に類似して、グリセリン450g、3M苛性ソーダ
溶液4.8g、アスコルビルパルミテート6g及びひま
わり油205gからなる混合物を最初に60℃で5分間
乳化させた。引続き該エマルジョンを30℃に冷却し、
800バールの高圧ホモジナイザーを1回通過させて均
質化した。平均粒度0.3μm及び30%のオイル含量
を有するエマルジョンが得られた。Example 3 Analogously to Example 1, a mixture consisting of 450 g of glycerin, 4.8 g of 3M sodium hydroxide solution, 6 g of ascorbyl palmitate and 205 g of sunflower oil was first emulsified at 60 ° C. for 5 minutes. The emulsion is subsequently cooled to 30 ° C.
One pass through an 800 bar high pressure homogenizer was homogenized. An emulsion having an average particle size of 0.3 μm and an oil content of 30% was obtained.
【0025】例4 a)蒸留水56g及び3M苛性ソーダ溶液5.6gを1
00mlのビーカーに装入し、水浴中60℃に加熱し
た。次いでアスコルビルパルミテート7gを加え、該混
合物を電磁撹拌機で殆ど透明な溶液になるまで撹拌し
た。Example 4 a) 56 g of distilled water and 5.6 g of 3M sodium hydroxide solution
It was placed in a 00 ml beaker and heated to 60 ° C. in a water bath. Then 7 g of ascorbyl palmitate was added and the mixture was stirred with a magnetic stirrer until a nearly clear solution was obtained.
【0026】b)グリセリン385gを水浴中60℃に
加熱し、a)で製造した溶液と電磁撹拌機を用いて緩慢
に混合した。B) 385 g of glycerin were heated to 60 ° C. in a water bath and slowly mixed with the solution prepared in a) using a magnetic stirrer.
【0027】c)β−カロチン75g、α−トコフェロ
ール5.6g及び分留したココナッツ油166g(Troi
sdorf 在の Huels 社の Miglyol(R) 810)を500ml
の丸底フラスコに計量装入し、油浴中185℃に加熱
し、β−カロチンを溶解しながら櫂型撹拌機で25分間
撹拌した。C) 75 g of β-carotene, 5.6 g of α-tocopherol and 166 g of fractionated coconut oil (Troi
500 ml of Huels Miglyol (R) 810)
Was heated to 185 ° C. in an oil bath and stirred with a paddle-type stirrer for 25 minutes while dissolving β-carotene.
【0028】d)c)で製造した溶液をホモジナイザー
(例えば Ulltraturrax(R))を用いてb)で製造した溶
液中で2分間乳化させた。得られたエマルジョンを50
℃に冷却し、次いで800バールの高圧ホモジナイザー
を1回通過させて均質化した。D) The solution prepared in c) was emulsified for 2 minutes in a solution prepared in b) using a homogenizer (eg Ulltraturrax®). The obtained emulsion is
C. and then homogenized by passing once through a high-pressure homogenizer at 800 bar.
【0029】得られたエマルジョンは、平均粒度0.2
μm及び10.4%のβ−カロチン含量を有していた。The resulting emulsion has an average particle size of 0.2
It had a μm and a β-carotene content of 10.4%.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI A23L 2/00 A23D 9/00 514 (56)参考文献 特開 昭63−192715(JP,A) 特開 昭47−25220(JP,A) 特開 昭62−3748(JP,A) 特開 昭62−106837(JP,A) (58)調査した分野(Int.Cl.7,DB名) A23L 1/035 - 2/00 A23D 9/00 A23K 1/16 WPI(DIALOG)──────────────────────────────────────────────────続 き Continuation of the front page (51) Int.Cl. 7 Identification symbol FI A23L 2/00 A23D 9/00 514 (56) References JP-A-63-192715 (JP, A) JP-A-47-25220 ( JP, A) JP-A-62-2748 (JP, A) JP-A-62-106837 (JP, A) (58) Fields investigated (Int. Cl. 7 , DB name) A23L 1/035-2/00 A23D 9/00 A23K 1/16 WPI (DIALOG)
Claims (1)
その誘導体、カロチノイドおよび多不飽和脂肪酸のグリ
セリドから選択される少なくとも1種の微細に分散した
生理学的に認容される脂溶性物質1〜50質量%、 b)連続相として、液体製品に対して、グリセリンまた
は100:0〜50:50の割合のグリセリン/水99
〜50質量%を、 c)乳化剤および安定剤として、アスコルビルパルミテ
ートを使用して含有することを特徴とする、安定な液体
製品。1. As a main component: a) As a dispersed phase, vitamin A, D, E or K or
Its derivatives, carotenoids and polyunsaturated fatty acids
1 to 50% by weight of at least one finely dispersed, physiologically acceptable liposoluble substance selected from cerides , b) as a continuous phase, for liquid products, glycerin or
Is glycerin / water 99 in a ratio of 100: 0 to 50:50.
The 50 mass%, c) as an emulsifier and stabilizer, ascorbyl palmitate
A stable liquid product characterized by containing using a liquid.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4200728A DE4200728A1 (en) | 1992-01-14 | 1992-01-14 | STABLE, LIQUID PREPARATIONS OF FAT-SOLUBLE SUBSTANCES |
DE4200728.3 | 1992-01-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH05304903A JPH05304903A (en) | 1993-11-19 |
JP3190465B2 true JP3190465B2 (en) | 2001-07-23 |
Family
ID=6449481
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP00321993A Expired - Lifetime JP3190465B2 (en) | 1992-01-14 | 1993-01-12 | Stable liquid products containing fat-soluble substances |
Country Status (8)
Country | Link |
---|---|
US (1) | US5350773A (en) |
EP (1) | EP0551638B1 (en) |
JP (1) | JP3190465B2 (en) |
AT (1) | ATE138246T1 (en) |
CA (1) | CA2086847C (en) |
DE (2) | DE4200728A1 (en) |
DK (1) | DK0551638T3 (en) |
ES (1) | ES2086632T3 (en) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL111477A (en) * | 1994-10-31 | 1999-07-14 | Makhteshim Chem Works Ltd | Stable lycophene concentrates and process for their preparation |
US5965183A (en) * | 1994-10-31 | 1999-10-12 | Hartal; Dov | Stable lycopene concentrates and process for their preparation |
AU4715696A (en) * | 1995-01-31 | 1996-08-21 | Neurosearch A/S | Astaxanthin suspension |
US5747544A (en) * | 1995-10-31 | 1998-05-05 | Applied Food Biotechnology, Inc. | Method of using pure 3R-3'R stereoisomer of zeaxanthin to treat or prevent retinal degeneration in humans |
US5854015A (en) * | 1995-10-31 | 1998-12-29 | Applied Food Biotechnology, Inc. | Method of making pure 3R-3'R stereoisomer of zeaxanthin for human ingestion |
CA2188983C (en) | 1995-10-31 | 2001-02-27 | Kevin M. Garnett | Pure 3r-3'r stereoisomer of zeaxanthin for treating macular degeneration in humans |
US5827652A (en) | 1995-10-31 | 1998-10-27 | Applied Food Biotechnology, Inc. | Zeaxanthin formulations for human ingestion |
ES2206679T5 (en) † | 1996-01-22 | 2011-10-27 | Chr. Hansen A/S | WATER-DISPOSABLE COMPOSITIONS CONTAINING A HYDROPHOBIC NATURAL PIGMENT, ITS PREPARATION PROCEDURE AND ITS USE. |
DE19609476A1 (en) * | 1996-03-11 | 1997-09-18 | Basf Ag | Stable parenteral administration suitable carotenoid emulsions |
DE19630789A1 (en) * | 1996-07-31 | 1998-02-05 | Basf Ag | Physiologically effective amounts of beta-carotene-containing clear aqueous-alcoholic multivitamin solution |
DE19642359A1 (en) * | 1996-10-14 | 1998-04-16 | Basf Ag | Stable emulsions and dry powder from mixtures of fat-soluble vitamins, their production and use |
DE19653410A1 (en) | 1996-12-20 | 1998-06-25 | Basf Ag | Use of carotenoid solubilisates for coloring food and pharmaceutical preparations |
US6361783B2 (en) * | 1997-06-27 | 2002-03-26 | Reulon Consumer Products Corporation | Compositions containing stabilized ascorbic acid and related methods |
US6007856A (en) * | 1997-08-08 | 1999-12-28 | The Procter & Gamble Company | Oil-in-water dispersions of β-carotene and other carotenoids stable against oxidation prepared from water-dispersible beadlets having high concentrations of carotenoid |
EP0924301B1 (en) * | 1997-12-20 | 2005-03-02 | Goldschmidt AG | Enzymatic preparation of regioselective fatty acid esters of ascorbic acid |
DE19831865A1 (en) * | 1998-07-16 | 2000-01-20 | Basf Ag | Use of organic sulfur compounds as a means for bathochromic shifting of the UV / Vis absorption band of carotenoids |
DE19838636A1 (en) | 1998-08-26 | 2000-03-02 | Basf Ag | Carotenoid formulations containing a mixture of beta-carotene, lycopene and lutein |
US7393548B2 (en) * | 1999-03-22 | 2008-07-01 | J.P. M.E.D. Ltd. | Nano oil in glycerin emulsion |
IL129102A0 (en) * | 1999-03-22 | 2000-02-17 | J P M E D Ltd | An emulsion |
IL138616A0 (en) * | 2000-09-21 | 2001-10-31 | J P M E D Ltd | Oil in glycerin emulsion |
US6582721B1 (en) | 1999-09-17 | 2003-06-24 | Alcon, Inc. | Stable carotene-xanthophyll beadlet compositions and methods of use |
DE19951615A1 (en) * | 1999-10-26 | 2001-05-03 | Basf Ag | Process for the stabilization of liquid, aqueous preparations of fat-soluble substances |
US7691406B2 (en) * | 2000-10-27 | 2010-04-06 | ZeaVision LLC. | Zeaxanthin formulations for human ingestion |
US6936279B2 (en) * | 2002-06-18 | 2005-08-30 | Zeavision Llc | Microcrystalline zeaxanthin with high bioavailability in oily carrier formulations |
US8088363B2 (en) | 2002-10-28 | 2012-01-03 | Zeavision Llc | Protection against sunburn and skin problems with orally-ingested high-dosage zeaxanthin |
US9192586B2 (en) * | 2003-03-10 | 2015-11-24 | Zeavision Llc | Zeaxanthin formulations with additional ocular-active nutrients, for protecting eye health and treating eye disorders |
US20070082066A1 (en) * | 2003-05-07 | 2007-04-12 | Gierhart Dennis L | Use of zeaxanthin to reduce light hyper-sensitivity, photophobia, and medical conditions relating to light hyper-sensitivity |
US7541166B2 (en) * | 2003-09-19 | 2009-06-02 | Microfluidic Systems, Inc. | Sonication to selectively lyse different cell types |
US7941211B2 (en) * | 2003-11-17 | 2011-05-10 | Zeavision, Llc. | Preloading with macular pigment to improve photodynamic treatment of retinal vascular disorders |
US20060185034A1 (en) * | 2005-02-11 | 2006-08-17 | Kalamazoo Holdings, Inc. | Capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom |
US8592662B2 (en) | 2005-02-11 | 2013-11-26 | Kalamazoo Holdings, Inc. | Capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom |
ITFI20050029A1 (en) * | 2005-02-21 | 2006-08-22 | Genius S R L | PROCEDURE TO ENRICH AND INTEGRATE WITH ORGANIC ANTIOXIDANTS OLIVE OILS AND PRODUCT OBTAINED BY THIS PROCEDURE, AND PLANT TO IMPLEMENT THAT PROCEDURE |
CN100341427C (en) * | 2005-03-16 | 2007-10-10 | 新疆生命红果蔬制品有限公司 | Emulsified lycopene and its preparing process |
DE102005031464A1 (en) * | 2005-07-04 | 2007-01-18 | Basf Ag | Emulsifier system, emulsion and their use |
JP5368316B2 (en) | 2007-01-16 | 2013-12-18 | ビーエーエスエフ ソシエタス・ヨーロピア | Liquid preparations containing carotenoids |
BRPI0807583A2 (en) * | 2007-02-23 | 2014-07-01 | Basf Se | USE OF WATER DISPERSABLE CAROTENOID NANOParticles, A PROCESS FOR MODULATING FLAVOR OF MATTER COMPOSITIONS, AND FLAVOR MODULATOR |
MX2009008269A (en) * | 2007-02-23 | 2009-08-12 | Basf Se | Method for modulating the taste of material compisitions containing at least one high intensity sweetener (his). |
CN101112359B (en) * | 2007-07-31 | 2010-09-15 | 中国农业大学 | Method for preparing transparent water-dispersible concentrated liquor of beta-carotin |
ES2540222T5 (en) | 2007-11-29 | 2022-04-19 | Basf Se | Powdered carotenoid preparation for tinting beverages |
EP2343986B2 (en) * | 2008-10-07 | 2021-04-21 | Basf Se | Ready-to-use, stable emulsion |
DK2413710T3 (en) | 2009-03-30 | 2017-04-03 | Basf Se | USEFUL, STABLE SUSPENSION OF DELAMORFE BETA CAROTIN PARTICLES |
WO2011095970A1 (en) * | 2010-02-07 | 2011-08-11 | J.P.M.E.D. Ltd. | Hair follicle targeting compositions |
WO2012133246A1 (en) * | 2011-03-30 | 2012-10-04 | 富士フイルム株式会社 | Carotenoid-containing composition and method for producing same |
CN104287053B (en) * | 2014-09-30 | 2018-05-29 | 杭州娃哈哈科技有限公司 | A kind of emulsifying Water Soluble Compound antioxidant and preparation method thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2628930A (en) * | 1951-05-17 | 1953-02-17 | Hoffmann La Roche | Aqueous emulsions of lipoid-soluble vitamins |
US3384545A (en) * | 1965-03-09 | 1968-05-21 | Hoffmann La Roche | Injectable aqueous emulsions of fat soluble vitamins |
ZA738657B (en) * | 1973-01-05 | 1974-10-30 | Hoffmann La Roche | Emulsions |
DE3610191A1 (en) * | 1986-03-26 | 1987-10-01 | Basf Ag | METHOD FOR PRODUCING FINE-PART, WATER-DISPERSIBLE CAROTINOID PREPARATIONS |
GB8613196D0 (en) * | 1986-05-30 | 1986-07-02 | Beecham Group Plc | Compositions |
ES2052016T3 (en) * | 1988-09-29 | 1994-07-01 | Shiseido Co Ltd | EMULSIFIED COMPOSITION. |
-
1992
- 1992-01-14 DE DE4200728A patent/DE4200728A1/en not_active Withdrawn
- 1992-12-21 ES ES92121742T patent/ES2086632T3/en not_active Expired - Lifetime
- 1992-12-21 EP EP92121742A patent/EP0551638B1/en not_active Expired - Lifetime
- 1992-12-21 AT AT92121742T patent/ATE138246T1/en active
- 1992-12-21 DE DE59206373T patent/DE59206373D1/en not_active Expired - Lifetime
- 1992-12-21 DK DK92121742.8T patent/DK0551638T3/en active
-
1993
- 1993-01-07 CA CA002086847A patent/CA2086847C/en not_active Expired - Lifetime
- 1993-01-08 US US08/002,038 patent/US5350773A/en not_active Expired - Lifetime
- 1993-01-12 JP JP00321993A patent/JP3190465B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA2086847C (en) | 2003-03-04 |
ATE138246T1 (en) | 1996-06-15 |
CA2086847A1 (en) | 1993-07-15 |
EP0551638B1 (en) | 1996-05-22 |
ES2086632T3 (en) | 1996-07-01 |
DK0551638T3 (en) | 1996-06-17 |
EP0551638A1 (en) | 1993-07-21 |
DE4200728A1 (en) | 1993-07-15 |
US5350773A (en) | 1994-09-27 |
DE59206373D1 (en) | 1996-06-27 |
JPH05304903A (en) | 1993-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3190465B2 (en) | Stable liquid products containing fat-soluble substances | |
US10004670B2 (en) | Ready-to-use, stable emulsion | |
EP2280611B1 (en) | Compositions of fat-soluble active ingredients containing gum ghatti | |
EP0981969B1 (en) | Carotinoid compositions comprising a mixture of beta-carotene, lycopene and lutein | |
US20080207777A1 (en) | Emulsifier System, Emulsion and the Use Thereof | |
EP2111125B1 (en) | Liquid formulations comprising carotenoids | |
EP2413710A1 (en) | Ready-to-use, stable suspension of partially amorphous carotenoid particles | |
JP2009500151A (en) | Emulsifier systems, emulsions and their use | |
JPH07501211A (en) | carotenoid composition | |
DE60223569T2 (en) | ZEACAROTENE PAINTING FOR FOOD OR PHARMACEUTICALS | |
JP2002204673A (en) | Solid preparation having multicore structure | |
JPH10502626A (en) | Cold water dispersible composition of fat-soluble active substance | |
EP4215056A1 (en) | Pigment-loaded solid lipid nanoparticles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20010410 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090518 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100518 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100518 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110518 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120518 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120518 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130518 Year of fee payment: 12 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130518 Year of fee payment: 12 |